# Study to Evaluate a Prototype Non-Invasive BG Measurement System

> **NCT05023798** · — · UNKNOWN · sponsor: **Afon Technology** · enrollment: 50 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** ATD (device test)

## Key facts

- **NCT ID:** NCT05023798
- **Lead sponsor:** Afon Technology
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-15
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-08-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05023798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05023798, "Study to Evaluate a Prototype Non-Invasive BG Measurement System". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05023798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*